Guangzheng Eye Hospital Group Co., Ltd.
SZSE:002524.SZ
6.6 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,074.904 | 767.445 | 1,044.477 | 921.049 | 1,284.867 | 1,175.292 | 553.995 | 499.296 | 555.185 | 626.305 | 505.429 | 465.811 | 426.429 | 381.737 | 276.035 | 237.693 | 154.168 |
Cost of Revenue
| 697.937 | 575.921 | 709.196 | 606.037 | 800.735 | 831.415 | 453.455 | 408.058 | 364.847 | 535.333 | 423.126 | 398.719 | 365.966 | 329.95 | 230.618 | 196.237 | 131.377 |
Gross Profit
| 376.966 | 191.523 | 335.281 | 315.012 | 484.132 | 343.877 | 100.54 | 91.238 | 190.338 | 90.973 | 82.303 | 67.092 | 60.463 | 51.787 | 45.416 | 41.456 | 22.791 |
Gross Profit Ratio
| 0.351 | 0.25 | 0.321 | 0.342 | 0.377 | 0.293 | 0.181 | 0.183 | 0.343 | 0.145 | 0.163 | 0.144 | 0.142 | 0.136 | 0.165 | 0.174 | 0.148 |
Reseach & Development Expenses
| 4.965 | 0.856 | 3.959 | 0.542 | 0 | 0.718 | 0 | 0 | 0 | 0 | 13.455 | 14.462 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 33.897 | 35.027 | 40.36 | 43.719 | 53.032 | 58.369 | 21.178 | 21.922 | 19.899 | 27.858 | 14.023 | 12.32 | 12.136 | 16.743 | 6.519 | 6.138 | 3.624 |
Selling & Marketing Expenses
| 187.058 | 140.893 | 200.58 | 143.001 | 146.298 | 95.911 | 22.421 | 26.324 | 90.908 | 40.874 | 15.83 | 4.654 | 5.038 | 4.208 | 2.249 | 1.924 | 1.905 |
SG&A
| 220.955 | 175.921 | 240.94 | 186.72 | 199.33 | 154.28 | 43.6 | 48.246 | 110.808 | 68.732 | 29.853 | 16.974 | 17.174 | 20.95 | 8.768 | 8.062 | 5.529 |
Other Expenses
| 0.882 | 104.714 | 89.403 | 89.196 | 109.71 | -9.442 | -1.468 | 10.929 | 28.679 | 8.718 | 23.627 | 16.641 | 7.059 | 3.794 | 1.814 | -0.212 | -0.211 |
Operating Expenses
| 328.663 | 281.49 | 334.302 | 276.459 | 309.04 | 243.136 | 95.851 | 100.084 | 160.802 | 115.536 | 61.166 | 32.397 | 29.823 | 24.106 | 17.024 | 12.77 | 8.417 |
Operating Income
| 7.032 | 98.623 | 76.988 | 96.621 | 296.641 | -22.463 | 17.116 | 4.815 | 1.204 | -72.724 | -13.355 | 22.463 | 23.152 | 23.665 | 21.756 | 24.23 | 12.976 |
Operating Income Ratio
| 0.007 | 0.129 | 0.074 | 0.105 | 0.231 | -0.019 | 0.031 | 0.01 | 0.002 | -0.116 | -0.026 | 0.048 | 0.054 | 0.062 | 0.079 | 0.102 | 0.084 |
Total Other Income Expenses Net
| 0.882 | -174.204 | -32.052 | -50.669 | -80.445 | -132.646 | 10.958 | 22.46 | -0.183 | -39.442 | -10.864 | -1.447 | -1.456 | -0.222 | -4.823 | -4.668 | -1.609 |
Income Before Tax
| 7.913 | -75.58 | 44.936 | 45.952 | 216.196 | -31.905 | 15.648 | 13.614 | 29.353 | -64.006 | 10.273 | 33.248 | 29.184 | 27.459 | 23.57 | 24.018 | 12.766 |
Income Before Tax Ratio
| 0.007 | -0.098 | 0.043 | 0.05 | 0.168 | -0.027 | 0.028 | 0.027 | 0.053 | -0.102 | 0.02 | 0.071 | 0.068 | 0.072 | 0.085 | 0.101 | 0.083 |
Income Tax Expense
| -1.833 | 2.222 | 8.492 | 13.855 | 59.085 | 18.426 | 7.829 | 5.481 | 3.902 | 4.258 | 1.124 | 5.373 | 4.841 | 5.163 | 4.483 | 1.651 | 0.893 |
Net Income
| 9.255 | -77.802 | 36.927 | 32.097 | 157.111 | -74.821 | 5.416 | 4.842 | 6.497 | -87.657 | 1.55 | 27.875 | 24.344 | 22.296 | 19.087 | 22.367 | 11.872 |
Net Income Ratio
| 0.009 | -0.101 | 0.035 | 0.035 | 0.122 | -0.064 | 0.01 | 0.01 | 0.012 | -0.14 | 0.003 | 0.06 | 0.057 | 0.058 | 0.069 | 0.094 | 0.077 |
EPS
| 0.02 | -0.16 | 0.085 | 0.064 | 0.31 | -0.15 | 0.01 | 0.01 | 0.01 | -0.17 | 0.003 | 0.068 | 0.058 | 0.061 | 0.061 | 0.077 | 0.05 |
EPS Diluted
| 0.02 | -0.16 | 0.08 | 0.064 | 0.31 | -0.15 | 0.01 | 0.01 | 0.01 | -0.17 | 0.003 | 0.068 | 0.058 | 0.061 | 0.061 | 0.077 | 0.05 |
EBITDA
| 148.723 | 198.639 | 183.379 | 159.26 | 395.055 | 191.205 | 149.212 | 147.722 | 148.159 | 48.922 | 76.109 | 61.94 | 48.588 | 37.938 | 33.761 | 31.59 | 15.885 |
EBITDA Ratio
| 0.138 | 0.259 | 0.176 | 0.173 | 0.307 | 0.163 | 0.269 | 0.296 | 0.267 | 0.078 | 0.151 | 0.133 | 0.114 | 0.099 | 0.122 | 0.133 | 0.103 |